These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 740102

  • 1. Charcoal hemoperfusion for chronic renal failure.
    Siemsen AW, Dunea G, Mamdani BH, Guruprakash G.
    Nephron; 1978; 22(4-6):386-90. PubMed ID: 740102
    [Abstract] [Full Text] [Related]

  • 2. Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia.
    Stefoni S, Feliciangeli G, Coli L, Scolari MP, Bonomini V.
    Int J Artif Organs; 1981 Jul; 4(4):186-91. PubMed ID: 7327760
    [Abstract] [Full Text] [Related]

  • 3. Solute, amino acid, and hormone changes with coated charcoal hemoperfusion in uremia.
    Winchester JF, Ratcliffe JG, Carlyle E, Kennedy AC.
    Kidney Int; 1978 Jul; 14(1):74-81. PubMed ID: 682427
    [Abstract] [Full Text] [Related]

  • 4. CAPD plus hemoperfusion once a week for end stage renal disease.
    Capodicasa G, De Santo NG, Galione A, Bellavia C, Annaloro R, Vaccaro F, Picone F, Vinti V, Davi G, Rapisarda LM, Giordano C.
    Int J Artif Organs; 1982 May; 5(3):125-9. PubMed ID: 7107045
    [No Abstract] [Full Text] [Related]

  • 5. Comparative studies on the effect of hemoperfusion and hemodialysis on the elimination of some uremic toxins.
    Trznadel K, Walasek L, Kidawa Z, Lutz W.
    Clin Nephrol; 1978 Dec; 10(6):229-31. PubMed ID: 729215
    [Abstract] [Full Text] [Related]

  • 6. Long-term clinical assessment of combined ACAC hemoperfusion-ultrafiltration in uremia.
    Chang TM, Chirito E, Barre P, Cole C, Lister C, Resurreccion E.
    Artif Organs; 1979 May; 3(2):127-31. PubMed ID: 533395
    [Abstract] [Full Text] [Related]

  • 7. CAPD + hemoperfusion once a week in the management of children with end-stage renal disease.
    Capodicasa G, De Santo NG, Vaccaro F, Manzo M, Maione S, Capasso G, Giordano C.
    Int J Artif Organs; 1983 Sep; 6(5):241-5. PubMed ID: 6642721
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of calcium chelating agents and prostaglandin E to eliminate platelet and white blood cell losses resulting from hemoperfusion through uncoated charcoal, albumin-agarose gel, and neutral and cation exchange resins.
    Scharschmidt BF, Martin JF, Shapiro LJ, Plotz PH, Berk PD.
    J Lab Clin Med; 1977 Jan; 89(1):110-9. PubMed ID: 401516
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hyperoxalemia in renal failure and the role of hemoperfusion and hemodialysis in primary oxalosis.
    Ahmad S, Hatch M.
    Nephron; 1985 Jan; 41(3):235-40. PubMed ID: 4058624
    [Abstract] [Full Text] [Related]

  • 12. Chlorpropamide overdose in renal failure: management with charcoal hemoperfusion.
    Ludwig SM, McKenzie J, Faiman C.
    Am J Kidney Dis; 1987 Dec; 10(6):457-60. PubMed ID: 3687936
    [Abstract] [Full Text] [Related]

  • 13. [Possibilities of using hemoperfusion in the treatment of chronic kidney insufficiency].
    Falkenhagen D, Holtz M, Schmidt R, Osten B, Klinkmann H.
    Z Urol Nephrol; 1979 Jan; 72(1):9-16. PubMed ID: 371244
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Platelet thromboxane formation and BTG levels after intensive charcoal HP in uremics or regular hemodialytic treatment (RHT).
    Capodicasa G, Daví G, Picone F, Mattina A, Giannetto V, Vinti V, Vaccaro F, Strano A, De Santo NG, Giordano C.
    Int J Artif Organs; 1983 Jul; 6(4):183-6. PubMed ID: 6195116
    [Abstract] [Full Text] [Related]

  • 16. [The effect of hemoperfusion through activated charcoal on middle molecular substances in the plasma during a long-term dialysis program].
    Mydlík M, Dzúrik R, Derzsiová K, Spustová V.
    Cas Lek Cesk; 1983 Dec 23; 122(51):1573-6. PubMed ID: 6652672
    [No Abstract] [Full Text] [Related]

  • 17. Charcoal hemoperfusion in a child with vancomycin overdose and chronic renal failure.
    Panzarino VM, Feldstein TJ, Kashtan CE.
    Pediatr Nephrol; 1998 Jan 23; 12(1):63-4. PubMed ID: 9502571
    [Abstract] [Full Text] [Related]

  • 18. Use of combined hemodialysis/hemoperfusion in chronic uremia.
    Stefoni S, Feliciangeli G, Colì L, Prandini R, Bonomini V.
    Contrib Nephrol; 1982 Jan 23; 29():123-32. PubMed ID: 6804167
    [Abstract] [Full Text] [Related]

  • 19. Effect of hemoperfusion with coated and uncoated charcoal on human blood in vitro.
    Ott NT, Kohnle W, Scheck R, Konstantin P, Franz HE.
    J Dial; 1979 Jan 23; 3(4):291-308. PubMed ID: 263952
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.